MP Biomedicals Germany GmbH has announced as of June 1, 2021, that its Rapid SARS-CoV-2 Antigen Test Card has been CE certified for self-testing.
In the face of the COVID-19 pandemic, MP Biomedicals is highly committed to developing diagnostic products to detect and prevent the spread of the virus. The development of the Rapid SARS-CoV-2 Antigen Test Card is a key milestone in this process.
MP Biomedicals now provides the rapid antigen test as a CE marked self-test. This test is used to detect SARS-CoV-2 antigens, in 15 minutes, based on a nasal swab sample from people suspected of COVID-19.
• EASY TO USE: Easy sampling using anterior nasal swab specimens
• RAPID: Results in 15 minutes
• CONVENIENT: Works with a nasal swab from 2.5 centimeters
• EXCELLENT PERFORMANCE CHARACTERISTICS: Specificity 99.20%, Sensitivity 96.77%, Accuracy 98.72
• PACKAGE: Includes all required consumable materials
• NO CROSS-CONTAMINATION with other coronaviruses like MERS, 229E, NL63, OC43 or influenza A, or B
The MP Biomedicals Rapid SARS-CoV-2 Antigen Test Card has already widely been used in Europe for self-testing. It had previously been approved for self-testing in Germany, the Netherlands, Luxembourg, and Czech Republic without finalization of conformity assessment proceedings.
For more information, please visit: https://www.mpbio-antigen.com/en/
